WT
AZN icon

Wilmington Trust’s AstraZeneca AZN Stock Holding History

Wilmington Trust’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		$4.17M Sell
56,091
-15,122
-21% -$1.09M 0.07% 167
2014
Q1 		$4.62M Sell
71,213
-1,352
-2% -$87.3K 0.08% 156
2013
Q4 		$4.31M Buy
72,565
+13,234
+22% +$719K 0.07% 163
2013
Q3 		$3.08M Sell
59,331
-884
-1% -$44.4K 0.05% 194
2013
Q2 		$2.85M Buy
+60,215
New +$3.07M 0.06% 192

Other funds holding AZN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
MCM
Mason Capital Management New York $613M AUM 21.43% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
SCCM
Schafer Cullen Capital Management New York $491M AUM 41.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Wilmington Trust's AZN Position: Q2 2014 in Review

Wilmington Trust reduced its AstraZeneca (AZN) stake by 21% in Q2 2014, selling an estimated $1.09M and leaving 56,091 shares worth $4.17M. The position accounts for 0.07% of the portfolio, ranked #167.

Wilmington Trust first reported a position in AZN in Q2 2013 and has held it in 5 quarters since. The position peaked at $4.62M in Q1 2014. 419 funds tracked by Wall St. Rank hold AZN as of Q2 2014.

  • Wilmington Trust held 56,091 shares of AstraZeneca worth $4.17M as of Q2 2014.
  • Wilmington Trust sold 15,122 AstraZeneca shares in Q2 2014, an estimated $1.09M.
  • AstraZeneca made up 0.07% of Wilmington Trust's portfolio in Q2 2014, its #167 holding.
  • Wilmington Trust first reported a position in AstraZeneca in Q2 2013 and has held it in 5 quarters since.
  • Wilmington Trust's AstraZeneca position peaked at $4.62M in Q1 2014.
  • 419 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2014.

Based on Wilmington Trust's 13F filing for Q2 2014, filed 13 Aug 2014.